Biomarin Pharmaceutical Inc. (BMRN)
NASDAQ · Healthcare
Biomarin Pharmaceutical Inc. Operating Income 2008–2025
Biomarin Pharmaceutical Inc. annual/quarterly operating income history and growth rate from 2008 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Biomarin Pharmaceutical Inc. operating income for the quarter ending March 31, 2026 was 129.6 M, a 42.10% decrease year-over-year.
- Biomarin Pharmaceutical Inc. operating income for the twelve months ending March 31, 2026 was 583.7 M, a 65.21% increase year-over-year.
- Biomarin Pharmaceutical Inc. annual operating income for 2025 was 409.5 M, a 15.43% decrease from 2024.
- Biomarin Pharmaceutical Inc. annual operating income for 2024 was 484.2 M, a 160.65% increase from 2023.
- Biomarin Pharmaceutical Inc. annual operating income for 2023 was 185.8 M, a 15.41% increase from 2022.
- Biomarin Pharmaceutical Inc. annual operating income for 2022 was 161.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Biomarin Pharmaceutical Inc. Operating Income — FAQ
Biomarin Pharmaceutical Inc. (BMRN) operating income over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is Biomarin Pharmaceutical Inc.'s operating income?
Biomarin Pharmaceutical Inc. (BMRN) reported operating income of $409M for fiscal 2025.
Where can I see BMRN's operating income history?
The chart and table above show Biomarin Pharmaceutical Inc.'s operating income by year and by quarter, including the growth rate.